Interview: OurCrowd CEO Jon Medved On Israel’s Medtech 'Boomtown'
Executive Summary
With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.